Abstract
The vast majority of the world's 42 million blind are needlessly impaired. Epidemiologic studies are providing important insights into the cause of cataracts and provision of surgical services; ecologic approaches to the control of trachomatous corneal scarring; treatment and prevention of onchocerciasis; and early diagnosis and treatment of xerophthalmia among others. Continued research and application of existing knowledge can have a dramatic impact on the sight and lives of millions of people.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 31-35 |
| Number of pages | 5 |
| Journal | Australian and New Zealand Journal of Ophthalmology |
| Volume | 16 |
| Issue number | 1 |
| State | Published - 1988 |
Fingerprint
ASJC Scopus subject areas
- Ophthalmology
Cite this
Avoidable blindness. / Sommer, Alfred.
In: Australian and New Zealand Journal of Ophthalmology, Vol. 16, No. 1, 1988, p. 31-35.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Avoidable blindness
AU - Sommer, Alfred
PY - 1988
Y1 - 1988
N2 - The vast majority of the world's 42 million blind are needlessly impaired. Epidemiologic studies are providing important insights into the cause of cataracts and provision of surgical services; ecologic approaches to the control of trachomatous corneal scarring; treatment and prevention of onchocerciasis; and early diagnosis and treatment of xerophthalmia among others. Continued research and application of existing knowledge can have a dramatic impact on the sight and lives of millions of people.
AB - The vast majority of the world's 42 million blind are needlessly impaired. Epidemiologic studies are providing important insights into the cause of cataracts and provision of surgical services; ecologic approaches to the control of trachomatous corneal scarring; treatment and prevention of onchocerciasis; and early diagnosis and treatment of xerophthalmia among others. Continued research and application of existing knowledge can have a dramatic impact on the sight and lives of millions of people.
UR - http://www.scopus.com/inward/record.url?scp=0023948485&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023948485&partnerID=8YFLogxK
M3 - Article
C2 - 3042000
AN - SCOPUS:0023948485
VL - 16
SP - 31
EP - 35
JO - Clinical and Experimental Ophthalmology
JF - Clinical and Experimental Ophthalmology
SN - 1442-6404
IS - 1
ER -